U.S. flag

An official website of the United States government

NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter) AND T-B+ severe combined immunodeficiency due to JAK3 deficiency

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 21, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001963164.7

Allele description [Variation Report for NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter)]

NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter)

Gene:
JAK3:Janus kinase 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.11
Genomic location:
Preferred name:
NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter)
Other names:
NM_000215.4(JAK3):c.2311C>T; p.Arg771Ter
HGVS:
  • NC_000019.10:g.17834610G>A
  • NG_007273.1:g.18382C>T
  • NM_000215.4:c.2311C>TMANE SELECT
  • NP_000206.2:p.Arg771Ter
  • LRG_77:g.18382C>T
  • NC_000019.9:g.17945419G>A
Protein change:
R771*
Links:
dbSNP: rs1198251679
NCBI 1000 Genomes Browser:
rs1198251679
Molecular consequence:
  • NM_000215.4:c.2311C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
T-B+ severe combined immunodeficiency due to JAK3 deficiency
Synonyms:
SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE; Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative; SCID, autosomal recessive, T-negative/B-positive type
Identifiers:
MONDO: MONDO:0010938; MedGen: C1833275; Orphanet: 35078; OMIM: 600802

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002243708Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 28, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004809134ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen SCID ACMG Specifications JAK3 V1.0.0)
Pathogenic
(Feb 21, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, O'Shea JJ, Leonard WJ.

Science. 1995 Nov 3;270(5237):797-800.

PubMed [citation]
PMID:
7481768

Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.

Mella P, Schumacher RF, Cranston T, de Saint Basile G, Savoldi G, Notarangelo LD.

Hum Mutat. 2001 Oct;18(4):355-6.

PubMed [citation]
PMID:
11668621
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002243708.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1459771). This premature translational stop signal has been observed in individual(s) with severe combined immunodeficiency (PMID: 11668621). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Arg771*) in the JAK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAK3 are known to be pathogenic (PMID: 7481768, 11668621).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen, SCV004809134.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter) variant in JAK3 is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 17/24 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The Filtering allele frequency (the upper threshold of the 95% confidence of 16/1111980) is 0.00001439 for European (non-Finnish) chromosomes by gnomeAD v 4.0.0, which is lower than the ClinGen SCID JAK3 VCEP threshold [(<0,000115)] for PM2_Supporting, and therefore meets this criterion (PM2_Supporting) At least one patient with this variant displayed: * Diagnostic criteria for SCID/Leaky SCID/Omenn syndrome met (0.5pt) and *T-B+NK- lymphocyte subset profile (0.5pt), totalizing 1 points, which is highly specific for SCID (PP4) (PMID: 32445296). In addition, this variant has been detected in at least two individuals with SCID, in the homozygous state (PMID: 11668610, 32445296) (total points= 1.0 pt) (PM3). One additional patient was found on Clinvar; however, the affected status is unknown (VCV001459771.4) In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PVS1, PP4, PM2_supporting and PM3. (VCEP specifications version 1).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024